JAZZ
Jazz Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · IE
$232.12
+1.04%Next report
Analyst consensus
- Next report date
- Feb 23, 2027
- EPS estimate
- $6.95
- Revenue estimate
- $1.3B
Latest reported
- Last report date
- Nov 2, 2026
- EPS actual
- -$3.88
- EPS estimate
- -$4.04
- Revenue actual
- $1.2B
- Revenue estimate
- $1.2B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +8.1%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $307
- PT range
- $275 – $337
- Analysts
- 9
9 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 2, 2026 | -$4.03 | -$3.88 | Beat 3.72% | $1.2B |
| Aug 3, 2026 | $6.18 | $5.71 | Miss -7.61% | $1.2B |
| May 5, 2026 | $4.67 | $6.34 | Beat 35.76% | $1.1B |
| Feb 24, 2026 | $6.62 | $6.64 | Beat 0.30% | $1.2B |
| Nov 5, 2025 | $5.95 | $8.13 | Beat 36.64% | $1.1B |
| Feb 25, 2025 | $5.83 | $6.60 | Beat 13.21% | $1.1B |
| Jul 31, 2024 | $4.68 | $5.30 | Beat 13.25% | $1.0B |
| May 1, 2024 | $4.14 | $2.68 | Miss -35.27% | $902.0M |
| Feb 28, 2024 | $5.26 | $5.02 | Miss -4.56% | $1.0B |
| Mar 1, 2023 | $0.51 | -$0.07 | Miss -113.73% | $972.1M |
| Nov 9, 2022 | $4.72 | $5.17 | Beat 9.53% | $940.7M |
| Aug 3, 2022 | $4.20 | $4.30 | Beat 2.38% | $932.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Feb 23, 2027